Spinal Stabilization Technologies
Private Company
Funding information not available
Overview
Spinal Stabilization Technologies is a clinical-stage medical device company pioneering a novel, less invasive approach to treating discogenic low back pain through nucleus replacement. Its core technology, the PerQdisc™ system, is an in-situ formed silicone-based prosthesis designed to replace the diseased nucleus pulposus, emulate its natural biomechanics, and redistribute spinal loads. The company is currently advancing the PerQdisc through a series of clinical trials (N161, N181, LOPAIN, DISCPAIN1) to demonstrate safety and efficacy, with the device not yet approved for commercial sale in key markets like the US or CE-mark regions.
Technology Platform
In-situ formed silicone-based nucleus pulposus replacement system designed to emulate native disc biomechanics and enable less invasive, motion-preserving spine surgery.
Opportunities
Risk Factors
Competitive Landscape
SST competes in the dynamic spine implant market against giants like Medtronic, Stryker, and Johnson & Johnson, who offer fusion and total disc replacement systems. It also faces competition from other nucleus replacement developers (e.g., Zimmer Biomet's NuCore, prior attempts like the DASCOR) and emerging motion-preserving technologies like annulus repair devices and dynamic stabilization systems.